Industry, regional funding and support organizations, the region’s university system and local and state government entities recognize this workforce challenge and have been collaborating to build the cell and gene therapy workforce infrastructure required to keep the personalized medicine workforce pipeline primed.
To discuss how the Biohealth Capital Region would fare out in a potential recession, and whether it can actually avoid one, the I-270 Innovation Labs brought together an outstanding group of regional experts from across key sectors connected to both industries.
A new biotech life sciences building, poised to be a solution for a multitude of companies, is coming to Germantown. Guardian Realty Investors has created Observation Labs, which will offer 67,300 square feet of life science space including spec suites and build-to-suit space when completed.
Dr. Tia Lyles-Williams, Chief Executive Officer of Philadelphia-based LucasPye Bio (LPB), a biologics contract development and manufacturing organization (CDMO), is ready to embrace the work ahead in order to expand opportunities for her company, as well as for other biomanufacturing organizations across the country.
With so many unknowns and an ever-shifting recruiting landscape, biotech and pharma hiring managers need all the help they can get to find the right people for their respective companies. One of the most important resources for hiring managers are search and staffing firms.
As more life science companies flock to the region a new challenge arises – how do we create a strong pipeline of local talent to support their needs? This pipeline not only includes the high concentration of experienced talent the BHCR is known for but entry-level employees and people without four-year degrees who can be trained on-the-job.
Catalent Biologics (Catalent), a global contract development and manufacturing organization (CDMO), is a leader in providing comprehensive solutions for life sciences companies of all sizes. Catalent’s 19,000+ employees and approximately 2,500 scientists partner with pharma, biotech, and consumer health companies to optimize product development, launch, and full life-cycle supply for patients around the world.
Whether you’re a current student, a recent graduate, taking a gap year, or simply at the beginning stages of your biotech career, an internship is widely acknowledged as one of the best ways to get your foot in the door of a company or field you’re interested in. Whether it be to enhance your skill set, make connections, or learn more about the life science industry, an internship can be an incredible stepping stone in achieving your future career goals- especially when considering that many successful internships turn into full-time position offers. But how do you get from point A to point B?
As long overdue change takes shape and the number of women in the biotech industry continues to grow, it is important to recognize those that have created the path for the next generation of diverse leaders. BioBuzz wishes to acknowledge the incredible contributions and efforts of women who have made their mark on the industry.
NextCure (Nasdaq: NXTC), a growing clinical-stage biotechnology company nestled in Beltsville, Maryland, is setting the example. The company works to create novel immunomedicines to treat cancer and other immune-related diseases, and if you’ve read some of BioBuzz’s previous stories you should know by now that when NextCure says they are committed to something, they truly are committed.
